Keywords: xanelim, effective, psoriasis, ph, iii, data, genentech

Xanelim effective in psoriasis; Ph III data

Article | 30 May 2001

Print This

Genentech and Xoma have said that their jointly-developed drug forpsoriasis, Xanelim (efalizumab), has met its endpoints at the interim stage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in